Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/29/2012WO2011139791A3 Bisphosphonamidate prodrugs and uses thereof
03/29/2012WO2011139379A3 A method of treating patients undergoing protein replacement therapy, gene replacement therapy, or other therapeutic modalities
03/29/2012WO2011137376A9 Compounds for anti-fungal treatment
03/29/2012WO2011133879A3 Combination therapies with mitochondrial-targeted anti-tumor agents
03/29/2012WO2011133827A3 Method of treating prostate cancer
03/29/2012WO2011131925A3 Osmium (ii) arene azo anti-cancer complexes
03/29/2012WO2011123524A3 Macrolide inhibitors of mtor
03/29/2012WO2011120327A9 Anti-tumor medicament of structure of diarylurea or thiourea kind based on indazole or aza-indazole
03/29/2012WO2011119777A3 Compositions and methods for treatment of neurodegenerative disease
03/29/2012WO2011119517A3 Antimicrobial compositions
03/29/2012WO2011116282A3 Nicotinic acetylcholine receptor agonists
03/29/2012WO2011116107A3 Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery
03/29/2012WO2011111066A3 Composition and uses thereof
03/29/2012WO2011109341A3 Oil composition containing carvone for use on aquatic creatures and amphibians
03/29/2012WO2011108009A3 Process for the preparation of fampridine
03/29/2012WO2011108006A8 A novel liquid oral spray dosage form comprising thiocolchicoside and anti-inflammatory agent
03/29/2012WO2011107855A3 Sustained release oral liquid suspension dosage form
03/29/2012WO2011101868A3 Stable pharmaceutical preparations containing clindamycin and benzoyl peroxide and method thereof
03/29/2012WO2011084593A3 Abuse-resistant formulations
03/29/2012WO2011080148A3 An aqueous intravenous nanosuspension with reduced adverse effects
03/29/2012WO2011071951A3 N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
03/29/2012WO2011071947A3 Bis-acylated hydroxylamine derivatives
03/29/2012WO2011057060A3 Copper salts of ion exchange materials for use in the treatment and prevention of infections
03/29/2012WO2011006263A8 Antibacterial oral composition
03/29/2012WO2011003662A3 Pressure control valve
03/29/2012WO2010149196A8 Taste masked dosage form of pharmaceutically acceptable salt of escitalopram
03/29/2012WO2010111777A8 Novel sodium channel blocking compounds tetrodotoxin galactopyranosides
03/29/2012WO2010076803A3 Topical compositions containing coated active agents
03/29/2012US20120079616 Npc1l1 (npc3) and methods of use thereof
03/29/2012US20120079613 Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
03/29/2012US20120078229 In vivo bioreactors and methods of making and using same
03/29/2012US20120078165 Element for implantation with medical device
03/29/2012US20120077985 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
03/29/2012US20120077979 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
03/29/2012US20120077884 Coccidiosis controlling agent and feed containing the same
03/29/2012US20120077883 Treatment of tinnitus and associated auditory dysfunctions
03/29/2012US20120077879 Process for making compositions with poorly compressible therapeutic compounds
03/29/2012US20120077878 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
03/29/2012US20120077877 Medium chain peroxycarboxylic acid compositions
03/29/2012US20120077876 Method For Improved Bioactivation Of Pharmaceuticals
03/29/2012US20120077875 Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections
03/29/2012US20120077874 Development of a phytoestrogen product for the prevention or treatment of osteoporosis using red clover
03/29/2012US20120077873 Methods of Reducing Blood Lactate Concentration
03/29/2012US20120077872 Preservative-free pharmaceutical tetrahydrolipstatin compositions
03/29/2012US20120077871 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof
03/29/2012US20120077869 Method and composition using a dual specificity protein tyrosine phosphatase as an antimalarial drug target
03/29/2012US20120077868 Use of Toll-like receptor-9 agonists, Toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of Toll-like receptor-4-associated disorders
03/29/2012US20120077867 Compositions And Methods For Treating Pancreatic Cancer
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077865 Methods for treating hypercholesterolemia
03/29/2012US20120077864 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
03/29/2012US20120077863 Guanidino-substituted bi-and polyphenyls as small molecule carriers
03/29/2012US20120077862 Antisense modulation of ptp1b expression
03/29/2012US20120077861 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
03/29/2012US20120077860 Adeno-Associated Viral Vector for Exon Skipping in a Gene Encoding a Dispensable Domain Protein
03/29/2012US20120077859 C-substituted Diindolylmethane Compositions and Methods for the Treatment of Multiple Cancers
03/29/2012US20120077858 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
03/29/2012US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/29/2012US20120077856 Pharmaceutical product
03/29/2012US20120077855 Crystalline tripeptide epoxy ketone protease inhibitors
03/29/2012US20120077854 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
03/29/2012US20120077853 Human protein tyrosine phosphatase inhibitors and methods of use
03/29/2012US20120077852 Hydroxypyridinones for the local treatment of skin microcirculatory disorders
03/29/2012US20120077851 Urea Derivatives as Kinase Inhibitors
03/29/2012US20120077850 Pirfenidone treatment for patients with atypical liver function
03/29/2012US20120077849 Inhaler for delivering a metered dose
03/29/2012US20120077848 Novel process to prepare pioglitazone via several novel intermediates
03/29/2012US20120077847 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
03/29/2012US20120077846 Treatment of renal cell carcinoma
03/29/2012US20120077845 Estrogen receptor ligands and methods of use thereof
03/29/2012US20120077843 Malignant precursor cells from ductal carcinoma in situ lesions
03/29/2012US20120077842 Quinoline derivative-containing pharmaceutical composition
03/29/2012US20120077841 Methods for cancer therapy and stem cell modulation
03/29/2012US20120077840 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
03/29/2012US20120077839 Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ol compounds and methods relating thereto
03/29/2012US20120077838 Beta-2-Adrenoreceptor Agonists
03/29/2012US20120077837 Anti-tumor agent
03/29/2012US20120077836 Methods of administering (4ar,10ar)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
03/29/2012US20120077835 Formulations of rifaximin and uses thereof
03/29/2012US20120077834 Methods of Use of Cyclopamine Analogs
03/29/2012US20120077833 Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
03/29/2012US20120077832 Besylate salt of a btk inhibitor
03/29/2012US20120077831 Methods and assays for the treatment of irritable bowel syndrome
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077829 Parenteral solutions containing metolazone
03/29/2012US20120077828 Chemical compounds
03/29/2012US20120077827 Zap-70 active compounds
03/29/2012US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists
03/29/2012US20120077825 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
03/29/2012US20120077824 Itraconazole formulations
03/29/2012US20120077823 Controlled release systems of pluribioactive antifungal drugs and applications thereof
03/29/2012US20120077822 In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
03/29/2012US20120077821 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/29/2012US20120077820 Compounds and method for treatment of cancer
03/29/2012US20120077819 Use of kinase inhibitor for the treatment of thymoma
03/29/2012US20120077818 Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof
03/29/2012US20120077817 Novel pharmaceutical compositions of ranolazine
03/29/2012US20120077816 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077814 Sulfonamide, sulfamate, and sulfamothioate derivatives
1 ... 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 ... 7860